Multi target molecular docking of Anantmul (Hemidesmus Indicus) compounds for Tay Sachs disease Treatment

Notice

This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.

Year : 2024 | Volume :02 | Issue : 02 | Page : –
By
vector

Suhas Sreehari,

  1. Student, Department of Biotechnology, B.M.S. College of Engineering, Bengaluru, Karnataka, India

Abstract document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_abs_129560’);});Edit Abstract & Keyword

The aim of this research was to study the effects of the plant Anantmul (Hemidesmus Indicus) in treatment of Tay Sachs Disease using molecular docking studies. Tay Sachs disease is a neurodegenerative autosomal recessive disorder caused due to accumulation of the molecule GM2 ganglioside which is caused due to lack of enzyme Beta Hexosaminidase which breaks down GM2 Ganglioside. Anantmul (Hemidesmus indicus) is a an ayurvedic plant used in the Indian subcontinent which has many medicinal uses such as anti-cancer, anti-diabetic, anti-inflammatory etc. using IMPATT software about 110 phytochemicals were discovered in Anantmul, then using SWISS ADME about 45 compounds were screened based on the Lipinski’s rule. Then they were further screened based on toxicity using protox software down to 11 compounds. These 11 compounds were selected for molecular docking analysis on the protein Hexosaminidase to study their interaction and binding energy. Out of these the top 6 compounds with the highest binding energy was taken for visualization. The compound with the highest binding energy was found to be Abieta 7 13 dien 18 oic acid with a binding energy of -7.4.

Keywords: Multi target molecular docking of Anantmul (Hemidesmus Indicus) compounds for Tay Sachs disease Treatment

[This article belongs to International Journal of Bioinformatics and Computational Biology (ijbcb)]

How to cite this article:
Suhas Sreehari. Multi target molecular docking of Anantmul (Hemidesmus Indicus) compounds for Tay Sachs disease Treatment. International Journal of Bioinformatics and Computational Biology. 2024; 02(02):-.
How to cite this URL:
Suhas Sreehari. Multi target molecular docking of Anantmul (Hemidesmus Indicus) compounds for Tay Sachs disease Treatment. International Journal of Bioinformatics and Computational Biology. 2024; 02(02):-. Available from: https://journals.stmjournals.com/ijbcb/article=2024/view=0

References
document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_ref_129560’);});Edit

Solovyeva VV, Shaimardanova AA, Chulpanova DS, Kitaeva KV, Chakrabarti L, Rizvanov AA. New approaches to Tay-Sachs disease therapy. Frontiers in physiology. 2018 Nov 20;9:1663.
2. Aneja V, Suthar A, Verma S, Kalkunte S. Phyto-pharmacology of Hemidesmus indicus. Pharmacognosy Reviews. 2008;2(3):143.

3. Karthikeyan Mohanraj Karthikeyan Mohanraj, B. S. Karthikeyan, R. P. Vivek-Ananth, R. P. B. Chand, S. R. Aparna, Pattulingam Mangalapandi. IMPPAT: a curated database of Indian Medicinal Plants, phytochemistry and therapeutics. 2018, Vol. 8, No. 1, 4329 ref. 105
4. Laskowski RA, Jabłońska J, Pravda L, Vařeková RS, Thornton JM. PDBsum: Structural summaries of PDB entries. Protein science. 2018 Jan;27(1):129-34.
5. Burley SK, Berman HM, Kleywegt GJ, Markley JL, Nakamura H, Velankar S. Protein Data Bank (PDB): the single global macromolecular structure archive. Protein crystallography: methods and protocols. 2017:627-41.
6. Dallakyan S, Olson AJ. Small-molecule library screening by docking with PyRx. Chemical biology: methods and protocols. 2015:243-50.
7. Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific reports. 2017 Mar 3;7(1):42717.
8. Xiong J, Hong ZL, Xu P, Zou Y, Yu SB, Yang GX, Hu JF. ent-Abietane diterpenoids with anti-neuroinflammatory activity from the rare Chloranthaceae plant Chloranthus oldhamii. Organic & Biomolecular Chemistry. 2016;14(20):4678-89.
9.Daroi PA, Dhage SN, Juvekar AR. p-Coumaric acid mitigates lipopolysaccharide induced brain damage via alleviating oxidative stress, inflammation and apoptosis. Journal of Pharmacy and Pharmacology. 2022 Apr 1;74(4):556-64.
10. Alipour HR, Yaghmaei P, Ahmadian S, Ghobeh M, Ebrahim-Habibi A. A study on alpha-terpineol in Alzheimer’s disease with the use of rodent in vivo model, restraint stress effect and in vitro Amyloid beta fibrils. Brazilian Journal of Pharmaceutical Sciences. 2022 May 6;58:e19090.
11. Huang S, Liu W, Li Y, Zhang K, Zheng X, Wu H, Tang G. Design, synthesis, and activity study of cinnamic acid derivatives as potent antineuroinflammatory agents. ACS Chemical Neuroscience. 2021 Jan 13;12(3):419-29.
12. Chowdhury S, Kumar S. Alpha-terpinyl acetate: A natural monoterpenoid from Elettaria cardamomum as multi-target directed ligand in Alzheimer’s disease. Journal of Functional Foods. 2020 May 1;68:103892.


Regular Issue Subscription Original Research
Volume 02
Issue 02
Received 21/11/2024
Accepted 02/12/2024
Published 28/12/2024